Informed-money record
Disclosed informed-money activity on this name over the last 12 months — corporate insiders, institutions, and members of Congress, from public-domain SEC and congressional filings. A dated factual record with receipts; interpretation is yours.
Bullish filings
7
Bearish filings
68
Named actors
19
Disclosed $ (bull / bear)
$4.2M / $86.1M
| Date | Who | What | Disclosed $ | Receipt |
|---|---|---|---|---|
| 2026-09-01 | Officer (via Fidelity Brokerage Services LLC) Davis J. E. | filed notice to sell | $2.4M | SEC ↗ |
| 2026-08-28 | SVP & General Counsel PREVOZNIK MICHAEL E | sold | $105K | SEC ↗ |
| 2026-08-28 | SVP & General Counsel PREVOZNIK MICHAEL E | gifted | — | SEC ↗ |
| 2026-08-28 | SVP & General Counsel PREVOZNIK MICHAEL E | sold | $3.9M | SEC ↗ |
| 2026-08-28 | SVP & General Counsel PREVOZNIK MICHAEL E | sold | $1.5M | SEC ↗ |
50 more disclosures in the window — the full record, scoring, and validation are for members.
Want the read, not just the record?
Members see how notable each move is, whether the actor's track record validates, cross-source convergence, and alerts on this name.
Create a free account →Events dated by when the activity occurred (a trade's transaction date; a notice, stake, or announcement at its filing date); the linked filing is the authoritative record. Directional public-domain disclosures only. Descriptive, not investment advice. Methodology · Today's notable signals
| 2026-08-28 | Officer (via Fidelity Brokerage Services LLC) PREVOZNIK MICHAEL E | filed notice to sell | $5.5M | SEC ↗ |
| 2026-07-28 | Officer (via Fidelity Brokerage Services LLC) DELANEY MARK E | filed notice to sell | $376K | SEC ↗ |
| 2026-07-23 | SVP, General Counsel Mike Prevoznik | adopted a selling plan | — | SEC ↗ |
| 2026-07-23 | SVP, Chief Commercial Officer Mark Delaney | adopted a selling plan | — | SEC ↗ |
| 2026-07-23 | Director Gary Pfeiffer | adopted a selling plan | — | SEC ↗ |
| 2026-06-30 | Institution (13F) MAVERICK CAPITAL LTD | exited a position | $540K | — |
| 2026-06-04 | SVP, Clinical Solutions KUPPUSAMY KARTHIK | sold | $1.6M | SEC ↗ |
| 2026-06-04 | Officer (via Fidelity Brokerage Services LLC) KUPPUSAMY KARTHIK | filed notice to sell | $1.6M | SEC ↗ |
| 2026-06-01 | CEO and President Davis J. E. | sold | $1.9M | SEC ↗ |
| 2026-06-01 | Officer (via Fidelity Brokerage Services LLC) Davis J. E. | filed notice to sell | $1.9M | SEC ↗ |
| 2026-04-30 | 5%+ holder (13G) VANGUARD CAPITAL MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-29 | 5%+ holder (13G) VANGUARD PORTFOLIO MANAGEMENT LLC | disclosed a passive stake (13G) | — | SEC ↗ |
| 2026-04-22 | SVP, Clinical Solutions Karthik Kuppusamy | adopted a selling plan | — | SEC ↗ |
| 2026-03-31 | Institution (13F) MAVERICK CAPITAL LTD | trimmed a position | $3.6M | — |
| 2026-03-30 | Congress Alan Armstrong | bought | $8K | — |
| 2026-03-27 | Congress Alan Armstrong | bought | $8K | — |
| 2026-03-05 | SVP for Diagnostic Services Plewman Patrick | sold | $589K | SEC ↗ |
| 2026-03-05 | SVP & General Counsel PREVOZNIK MICHAEL E | sold | $800K | SEC ↗ |
| 2026-03-05 | EVP, Regional Businesses Doherty Catherine T. | sold | $1.1M | SEC ↗ |
| 2026-03-05 | Officer (via Fidelity Brokerage Services LLC) Plewman Patrick | filed notice to sell | $589K | SEC ↗ |